ATRC · ISSUER CIK 1323885
AtriCure, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 6 AtriCure, Inc. insiders reported $0.00 of open-market purchases and $1.9M of sales on SEC Form 4.
↗6 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 3 of 7 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$1.9MInsider selling
−$1.9MNet open-market
Sep 24, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 24, 202617:00 | Sep 23, 2026 | ATRC | Chief Technical Officer | S · Sell10b5-1 | $60.00 | −4,519 | 142,745 | -3% | −$271K | ||
| Sep 14, 202617:44 | Sep 11, 2026 | ATRC | Director | S · Sell | $54.22 | −5,313 | 34,546 | -13% | −$288K | ||
| Sep 10, 202609:18 | Sep 8, 2026 | ATRC | Chief Technical Officer | S · Sell10b5-1 | $55.00 | −3,657 | 147,264 | -2% | −$201K | ||
| Sep 4, 202607:39 | Sep 2, 2026 | ATRC | Chief Technical Officer | S · Sell10b5-1 | $52.50 | −7,763 | 150,921 | -5% | −$408K | ||
| Aug 26, 202606:50 | Aug 24, 2026 | ATRC | Chief Legal Officer | S · Sell | $48.89 | −9,370 | 87,319 | -10% | −$458K | ||
| Aug 7, 202609:18 | Aug 5, 2026 | ATRC | Director | S · Sell | $38.80 | −3,564 | 22,809 | -14% | −$138K | ||
| Aug 7, 202609:18 | Aug 5, 2026 | ATRC | Director | S · Sell | $38.42 | −3,500 | 14,015 | -20% | −$134K | ||
| Aug 3, 202607:18 | Jul 30, 2026 | ATRC | President, CEO, & Director, Director | G · Gift | — | −4,700 | 774,434 | -1% | — |